127 results
8-K
EX-99.1
EBS
Emergent Biosolutions Inc
29 May 24
Departure of Directors or Certain Officers
7:34am
, & Corporate Secretary
PROPRIETARY AND CONFIDENTIAL 3 J O S E P H PA PA P R E S I D E N T , C H I E F E X E C U T I V E O F F I C E R & D I R E C T O R
8-K
EX-99.1
EBS
Emergent Biosolutions Inc
1 May 24
Emergent Biosolutions Reports First Quarter 2024 Financial Results
4:44pm
% Change
Cost of Commercial product sales
Cost of MCM product sales
Cost of Bioservices
Research and development (“R&D”)
Selling, general … Expenses
For Q1 2024, R&D expenses decreased $25.6 million, or 63%, as compared with Q1 2023. The decrease was primarily due to the sale of our development
8-K
EX-99.2
EBS
Emergent Biosolutions Inc
1 May 24
Emergent Biosolutions Reports First Quarter 2024 Financial Results
4:44pm
R&D $ Q1 2024 Q1 2023 $52.1 $45.8 $62.2 $55.4 $30.3 $51.7
Segment Reporting Q1 2024 vs. Q1 20231 11 Revenue Segment Adjusted Gross Margin 2 … ) Q2 2024 Forecast Total revenues $160 - $210 Key Assumptions ($ and shares in millions) Updated Range (as of 05/01/2024) Interest expense ~$82 R&D ~6
8-K
EX-99.2
tfuj uy2b
6 Mar 24
Emergent Biosolutions Reports Fourth Quarter 2023 Financial Results
4:15pm
8-K
EX-99.1
o2wwzr5 kqrv15
6 Mar 24
Emergent Biosolutions Reports Fourth Quarter 2023 Financial Results
4:15pm
8-K
EX-99.2
25htae1br c982bi5xi
9 Jan 24
Regulation FD Disclosure
8:40am
8-K
EX-99.1
bgmqcns15hep587akb0w
8 Nov 23
Emergent Biosolutions Reports Third Quarter 2023 Financial Results
4:21pm
8-K
EX-99.2
6df uz8wrg5j80ti
8 Nov 23
Emergent Biosolutions Reports Third Quarter 2023 Financial Results
4:21pm
8-K
EX-99.1
esrz0dpptr6i5m q1
8 Aug 23
Emergent Biosolutions Reports Financial Results for Second Quarter 2023
4:12pm
8-K
EX-99.2
iv3lzv2xt
8 Aug 23
Emergent Biosolutions Reports Financial Results for Second Quarter 2023
4:12pm
8-K
EX-99.1
c9vqgish qybyom
9 May 23
Emergent Biosolutions Reports Financial Results for First Quarter 2023
4:05pm
8-K
EX-99.2
3n8auddnur xsy
9 May 23
Emergent Biosolutions Reports Financial Results for First Quarter 2023
4:05pm
DEFR14A
nb5d rvpe
24 Apr 23
Revised proxy
9:32am